FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
The efficacy of apremilast in pemphigus: a systematic review of case reports
1053PDF: 465SUPPLEMENTARY MATERIAL: 70HTML: 20 -
11 | EFFICACY AND SAFETY OF LEBRIKIZUMAB IS MAINTAINED UP TO 4 YEARS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: FIRST YEAR OF ADLONG LONG-TERM EXTENSION TRIAL L. Stingeni1, S. Weidinger2, A. Irvine3, D. Thaçi4, J. Szepietowski5, T. Biedermann6, H. Agell7, Y. Mihaylov7, B. Kostov7, R. Coll7, W. Romero8, K. Reich9 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; 3Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 4Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 5Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland; 6Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany; 7Almirall S.A., Barcelona, Spain; 8Eli Lilly and Company, Indianapolis, IN, USA; 9Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
101PDF: 32 -
-
Secondary prevention of hidradenitis suppurativa
3121PDF: 1253HTML: 45 -
Blue diode laser as supportive therapy for the management of vulvar lichen sclerosus
2691PDF: 830SUPPLEMENTARY MATERIAL: 279HTML: 153 -
Isotretinoin musculoskeletal side effects: a systematic review
6207PDF: 1228SUPPLEMENTARY: 467HTML: 499

